Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1128 | 1096 | 1164 | 1421 | 1634 | 2468 |
Fund Return | 12.82% | 9.62% | 16.4% | 12.43% | 10.31% | 9.45% |
Place in category | 707 | 980 | 504 | 651 | 323 | 305 |
% in Category | 32 | 45 | 23 | 38 | 20 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Sverige Index A1 SEK | 66.52B | 7.50 | 4.47 | 10.11 | ||
Handelsbanken Sverige Index B1 SEK | 66.52B | 7.50 | 4.47 | 9.63 | ||
Handelsbanken MSCI USA Index | 53.21B | 16.34 | 16.70 | 18.25 | ||
Handelsbanken MSCI USA Index utd | 53.21B | 16.34 | 16.70 | 17.75 | ||
Handelsbanken European Index utd | 18.73B | 12.82 | 12.43 | 8.97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken European Index utd | 18.73B | 12.82 | 12.43 | 8.97 | ||
SPP Aktiefond Europa | 17.15B | 12.19 | 12.76 | 9.46 | ||
Swedbank Robur Access Europa | 15.05B | 15.69 | 15.26 | 9.92 | ||
FI4000048988 | 10.86B | 11.71 | 11.06 | 9.95 | ||
Lansforsakringar Europa Indexnara | 10.65B | 12.29 | 12.48 | 9.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.53 | 927.3 | +1.13% | |
ASML Holding | NL0010273215 | 3.95 | 870.80 | -1.16% | |
Nestle | CH0038863350 | 2.87 | 95.56 | +1.51% | |
AstraZeneca | GB0009895292 | 2.64 | 12,190.0 | +1.35% | |
Novartis | CH0012005267 | 2.27 | 92.96 | +1.90% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review